SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
cas2238-sup-0001-figS1.tifimage/tif2663KFig. S1. Compound 20d (comp.20d) inhibits vascular endothelial growth factor (VEGF)-mediated cell migration.
cas2238-sup-0002-figS2.tifimage/tif2165KFig. S2. Body weight change during compound 20d (comp.20d) treatment shown in Figure 3(A).
cas2238-sup-0003-figS3.tifimage/tif2625KFig. S3. Plasma concentration of SN-38 during the combination treatment shown in Figure 4(C).
cas2238-sup-0004-figS4.tifimage/tif2822KFig. S4. Inhibition of compound 20d (comp.20d) towards vascular endothelial growth factor receptor 3 (VEGFR3) kinase activity.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.